The technical note describes a UPLC/MS/MS method for the analysis of clopidogrel and clopidogrel carboxylic acid metabolite.
The paper outlines:
- A high-sensitivity method for the analysis of clopidogrel and its carboxylic metabolite was developed with an LLOQ of 1 pg/mL
- Quality Control (QC) samples meet required acceptance criteria put forth by the U.S. FDA
- Both clopidogrel and the carboxylic acid metabolite were successfully separated from possible coeluting phospholipids
- There was no detectable carryover present
To read the full report, please click on the link above.
